Упрощенная HTML-версия
285
230.
Ketter N. Discordance between empiric combination therapy and pathogens
isolated in nosocomial pneumonia / N. Ketter, R. Wunderink, R. Postier, M. Clavel,
S. Lodo, R. Redman, M. Lee, K. Kaniga, I. Friedland // Am. J. Respir. Crit. Care
Med. – 2009. – Vol. 179. – P. 1736.
231.
Khurana P.S. The dilemma of nosocomial pneumonia: what primary care
physicians should know / P.S. Khurana, D. Litaker // Cleve Clin. J. Med. – 2000. –
Vol. 67 (1). – P. 25-38.
232.
Kita M. Role of IFN-gamma in nonviral infection / M. Kita // Nippon.
Rinsho. – 2006. – Vol. 64 (7). – P. 1269-1274.
233.
Plasma CD14 decreases monocyte responses to LPS by transferring cell-
bound LPS to plasma lipoproteins / R.L. Kitchens [et al.] // J. Clin. Invest. – 2001. –
Vol. 108. – P. 485-493.
234.
Klevents R.M. The impact of antimicrobial-resistant, health care-associated
infections on mortality in the united states / R.M. Klevents, J.R. Edwards, R.P.
Gaynes // Clinical Infectious Diseases. – 2008. – Vol. 47 (1). – P. 927-930.
235.
Klompas M. Does this patient have ventilator-associated pneumonia? / M.
Klompas // Jama. – 2007. – Vol. 297. – P. 1583-1593.
236.
APACHE II: a severity of disease classification system / W.A. Knaus [et
al.] // Crit. Сare Med. – 1985. – Vol. 13. – P. 818-829.
237.
CD14 C(-260)→T polymorphism, plasma levels of the soluble endotoxin
receptor CD14, their association with chronic infection and risk of stable coronary
artery disease / W. Koenig [et al.] // J. Am. Coll. Cardiol. – 2002. – Vol. 40. – P.
34-42.
238.
Koenig S.M. Ventilator-associated pneumonia: diagnosis, treatment, and
prevention / S.M. Koenig, J.D. Truwit // Clinical Microbiology Reviews. – 2006. –
Vol. 19 (4). – P. 637-657.
239.
Transient expression of IL-1 beta induces acute lung injury and chronic
repair leading to pulmonary fibrosis / M.Kolb [et al.] // J. Clin. Invest. – 2001. –
Vol. 107. – P. 1529-1536.